Elena V. Gerasimova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype.

Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype.

Journal: Frontiers in immunology

Published: May 13, 2026

Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on "Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425".

Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on "Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425".

Journal: International journal of molecular sciences

Published: February 17, 2025

Dynamics of Modified Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis on the Background of 5-Year Therapy with an Interleukin 6 Receptor Inhibitor.

Dynamics of Modified Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis on the Background of 5-Year Therapy with an Interleukin 6 Receptor Inhibitor.

Journal: Doklady. Biochemistry and biophysics

Published: February 02, 2025

Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome.

Exploring the role of APRIL in autoimmunity: implications for therapeutic targeting in systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome.

Journal: Frontiers in immunology

Published: November 06, 2024

Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis.

Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis.

Journal: International journal of molecular sciences

Published: October 09, 2024

Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis.

Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis.

Journal: Frontiers in bioscience (Landmark edition)

Published: May 20, 2024

Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.

Proinflammatory Activation of Monocytes in Patients with Immunoinflammatory Rheumatic Diseases.

Journal: Doklady. Biochemistry and biophysics

Published: April 05, 2024

Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms.

Systemic Sclerosis and Atherosclerosis: Potential Cellular Biomarkers and Mechanisms.

Journal: Frontiers in bioscience (Scholar edition)

Published: October 22, 2023

Mitochondrial DNA copy number in patients with systemic sclerosis.

Mitochondrial DNA copy number in patients with systemic sclerosis.

Journal: Frontiers in molecular biosciences

Published: October 10, 2023

Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk

Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk

Journal: Terapevticheskii arkhiv

Published: July 16, 2023

Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk.

Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk.

Journal: Biomedicines

Published: February 17, 2023

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases.

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases.

Journal: International journal of molecular sciences

Published: June 05, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026